Technical Strength Analyser      Futures Screeners ,    Option Screeners
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Glenmark Pharmaceuticals , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Glenmark Pharmaceuticals Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeGLENMARK
EOD Share Price293.75
Previous Share Price295.9
Price Change -2.15
Change % -0.727%
Volume2441.59 K
Five Day Avg Vol3015.11 K
Beta0.989465
Fno StockYes, F&O list
Last Business Date27-Feb-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -27.80 -8.65
Two Weeks -33.85 -10.33
One Month -62.40 -17.52
Three Months -52.80 -15.24
Six Months -81.10 -21.64
One Year -289.80 -49.66

Highs / Lows

DurationHighLow
One Week318.0288.85
Two Weeks346.45288.85
One Month361.3288.85
Three Months365.2288.85
Six Months394.85267.25
One Year666.8267.25

Key Moving Average

MA SMAEMA
5 Days 300.84299.793
15 Days 315.337311.445
20 Days 313.78315.082
50 Days 333.831326.34
100 Days 325.671342.365
200 Days 385.598390.627
Detailed MA Analysis of GLENMARK ...

Key Technical Indicators

MACD -9.69
RSI 38.01
RSI (Smooth) 35.82
ADX 19.18
Chaikin Money Flow -0.286
Williams %R -91.49
PSAR 336.86
Detailed Tech Analysis GLENMARK ...

Financial Data Highlights

Market Cap8335.24
Book Value/ Share209.032
Enterprise Value1712.49
Revenue TTM10436.95
Gross Profit TTM6362.44
Revenue /Share TTM369.87
Consensus Target663.61
Key Financial Highlights GLENMARK ...

Financial Ratios of GLENMARK

EPS25.42
PE11.62
Div/Share2.00
Div Yield0.680
Trailing PE11.62
Forward PE7.96
Price/Book1.41
Key Financial Ratios of GLENMARK ...

Key Profit & Loss Data

Period31_Mar_2019Growth
Net Inc 924.99 15.07 %
Ops Income1259.90 4.23 %
Revenue9865.47 8.72 %
Ops Expense8605.57 10.91 %
PBT1300.63 16.20 %
Gross Profit6362.44 6.91 %
Div Paid-67.88 0 %
Key P&L GLENMARK ...

Futures of GLENMARK

Closing Price296.70
Premium/Discount 2.95
Price Change 4.40
Change % 1.51
Future OI7060.20 K
OI Change % 103.02
Future Contracts5855.00
Contracts Change 180.41
Lot Size1400

Put / Call Options

Call Max Traded Strike Price320.00
Call Max Traded SP Contracts274
Call Option Open Interest488.60 K
Call Option OI Chg % 34.75
Put Max Traded Strike Price290.00
Put Max Traded SP Contracts39
Put Option Open Interest212.80 K
Put Option OI Chg % 24.59
Option Chain With Impled Vol & Greeks ...

Put Call Ratio - 26/03/2020

Put Open Interest212.80 K
Call Open Interest488.60 K
PCR Open Interest0.436
PCR OI ReadingBullish
Put Contracts Traded117.00
Call Contracts Traded645.00
PCR Volume0.181
PCR Vol ReadingStrong Bullish
Put Call Ratio GLENMARK ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR11.253.83
Week PR29.159.92
Month PR57.6019.61
5 Day Period14.074.79
10 Day Period14.724.86
5 Week Period29.989.95
3 Months Period56.1518.75
Price Range /Volatility GLENMARK ...

Highlights & Chart Patterns of Glenmark Pharmaceuticals Ltd.

Share has hit Three Months high on 27-Feb-20.
Stock has fallen by more than 10% in last two weeks from its highest level of 346.45 dt 17-Feb-20.
Stock has fallen by more than 15% in last One Month from its highest level of 361.3 dt 28-Jan-20.
Stock has fallen to less than half in last One Year from its Highest level of 666.8 dt 29-Mar-19.
Stock - Glenmark Pharmaceuticals Ltd. has made lower level with higher volume market in downtrend
Stock - Glenmark Pharmaceuticals Ltd. has made lower level with higher volume market in downtrend
As Per ADX, stock is not trending with ADX of 19.1784 and is not trending for 11 Days
More Chart Patterns Glenmark Pharmaceuticals Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Glenmark Pharmaceuticals Ltd.

Date Open High Low Close Volume
27-Feb-20 297.50 300.10 288.85 293.75 2441 K
26-Feb-20 297.00 303.90 294.00 295.90 4896 K
25-Feb-20 303.00 307.75 290.75 292.10 3741 K
24-Feb-20 318.00 318.00 299.85 300.90 2466 K
20-Feb-20 318.10 325.95 317.70 321.55 1529 K
19-Feb-20 313.30 320.00 313.30 318.10 1742 K
18-Feb-20 312.30 314.00 303.15 311.95 2593 K
17-Feb-20 342.00 346.45 305.40 310.40 8581 K
14-Feb-20 329.55 337.30 328.00 333.80 2220 K
13-Feb-20 323.40 329.45 319.00 327.60 1134 K
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes GBR 830, which is in Phase 2b clinical trails for the treatment of atopic dermatitis; GRC 27864 that is in Phase 2b clinical trails for the treatment of osteoarthritic pain; and GRC 17536, which has completed Phase 2a clinical trails for the treatment of painful diabetic neuropathy. The company's products pipeline comprises GBR 1302, which is in Phase 1a/1b clinical trails for the treatment of breast cancer; and GBR 1342 that is in Phase 1a/1b clinical trails for the oncology; GRC 5xxxx, a MAP4K1 inhibitor compound, which is in pre-clinical studies for the treatment of cancer; and Ryaltris for allergic rhinitis. The company was founded in 1977 and is based in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.